Warning: Creating default object from empty value in /home3/raveh40/public_html/peritech-p.com/wp-content/themes/simplicity/functions/admin-hooks.php on line 160

Team

Dr. Eran Eilat M.D, Ph.D, Founder & CEO – a serial entrepreneur who has founded several biotechnology and medical device companies including, Otic Pharma which completed a successful phase II clinical trial, and then closed a significant financing round led by Orbimed, and AOPharma, which has developed a proprietary preservative free, multi-dose and user-friendly ophthalmic drug delivery device.
Dr. Eilat received an M.D. degree from the Sackler School of Medicine in Tel Aviv University, and a Ph.D. degree in Immunology from the Weizmann Institute of Science. He is the inventor of numerous patents in the medical and biotechnology fields.

Dr. Evgenia Lozinsky, VP of Research & Development – Dr. Lozinsky has more than 12 years of experience in development of formulations and drug delivery systems, including a position as a team leader in the R&D of Perrigo Israel. She has a thorough experience in formulation and Analytical Development of both generic as well as innovative products in both Rx and OTC, and a focus on topical dosage forms. Dr. Lozinsky is also the VP of R&D and Operations of the GC Group Ltd. She has a PhD in from the Chemistry-Ben-Gurion University. Throughout her career she has been the inventor of several patents.

Dr. Stephen Cherkez, VP of Intellectual Property- Dr. Cherkez is active in the chemical-pharmaceutical industry for more than 45 years. He earned a B.Sc. in Chemical Engineering from the Technion Institute and M.Sc. and Ph.D. degrees in pharmaceutical chemistry from the Tel-Aviv University. His professional career is divided in two almost equal halves. The first one was with Teva and the second  half with Agis (now Perrigo-Israel). He was Head of Teva’s Chemical Research, and in 1985 joined Agis (now Perrigo) as Founder and President of ChemAgis, an Agis daughter company founded by him. In 1993 he became VP Business Development of Agis and starting 2003 he held the double position of Perrigo International (Michigan) VP Intellectual Property and VP Product Development. Dr, Cherkez authored or co-authored 33 patent families and 8 scientific papers and presented many lectures in Israel and abroad. He was awarded by the Weizman Institute the Horev prize for excellence in Medicinal Chemistry and Drug Development and life achievements.

Raveh Gill-More, VP of Business Development- founder of BioMarketing Ltd., which offers marketing and BD services to the BioMed community. Among BioMarketing’s customers are leading players in the Israeli Biomed arena such as the Elron holding group (NASDAQ: ELRNF) and Alma Lasers.
Mr. Gill-More spent over twelve years in senior marketing and business development roles in life sciences companies including BrainsGate and Compugen (Nasdaq: CGEN). Mr. Gill-More is also the chairperson of the BioExecutive Forum, a pro-bono activity in an NPO dedicated to furthering networking and education among Israeli BioMed executives. Mr. Gill-More. holds an MBA from Heriot-Watt University, Edinburgh, an M.Sc. in Pure Math, and a B.Sc. in Math and Physics from the Tel-Aviv University.